Trial · NCT03348683
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time From Beginning of Induction to Delivery | Propranolol | 13.8 | Standard Deviation 5.4 | hours | |
| Time From Beginning of Induction to Delivery | Placebo | 14.3 | Standard Deviation 5.3 | hours | |
| Number of Participants With Various Mode of Delivery | Propranolol | Spontaneous vaginal delivery | 64 | Participants | |
| Number of Participants With Various Mode of Delivery | Placebo | Spontaneous vaginal delivery | 61 | Participants | |
| Number of Participants With Various Mode of Delivery | Propranolol | Vacuum assisted vaginal delivery | 3 | Participants | |
| Number of Participants With Various Mode of Delivery | Placebo | Vacuum assisted vaginal delivery | 10 | Participants | |
| Number of Participants With Various Mode of Delivery | Propranolol | Forceps assisted vaginal delivery | 8 | Participants | |
| Number of Participants With Various Mode of Delivery | Placebo | Forceps assisted vaginal delivery | 8 | Participants | |
| Number of Participants With Various Mode of Delivery | Propranolol | Cesarean section | 46 | Participants | |
| Number of Participants With Various Mode of Delivery | Placebo | Cesarean section | 40 | Participants | |
| Duration of Latent | Propranolol | 11.0 | Standard Deviation 5.0 | hours | |
| Duration of Latent | Placebo | 11.2 | Standard Deviation 4.5 | hours | |
| Number of Participants With Maternal Morbidity Composite Score = 1 | Propranolol | 35 | Participants | ||
| Number of Participants With Maternal Morbidity Composite Score = 1 | Placebo | 49 | Participants | ||
| Number of Participants With Postpartum Hemorrhage | Propranolol | 15 | Participants | ||
| Number of Participants With Postpartum Hemorrhage | Placebo | 26 | Participants | ||
| Number of Fetus With Heart Rate Decelerations | Propranolol | 15 | Participants | ||
| Number of Fetus With Heart Rate Decelerations | Placebo | 13 | Participants | ||
| Number of Fetus With Fetal Bradycardia | Propranolol | 1 | Participants | ||
| Number of Fetus With Fetal Bradycardia | Placebo | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03348683/results